文献速递冠心病

RIPCORD 2试验:常规压力导丝评估与常规造影在冠心病管理中的比较

Routine Pressure Wire Assessment Versus Conventional Angiography in the Management of Patients With Coronary Artery Disease: The RIPCORD 2 Trial.
PubMed 文献 · Circulation · 2022-08-10

RIPCORD 2是一项在17个英国中心开展的开放标签随机对照试验,纳入1100例因稳定型心绞痛或非ST段抬高型心肌梗死接受侵入性冠状动脉造影的患者,随机分为仅造影组或造影联合对所有直径>2.25 mm的心外膜血管进行系统压力导丝评估组。1年时,两组医院费用和健康相关生活质量无显著差异,临床事件复合终点亦无显著差异。

要点

  • 系统FFR评估未显著降低1年医院费用或改善生活质量。
  • 两组临床事件复合终点发生率相似(8.7% vs 9.5%,P=0.64)。
  • 对直径>2.25 mm心外膜血管行系统FFR评估中位检查血管数为4支。

核心结论

  • 与仅造影相比,系统FFR评估策略未显著降低费用或改善生活质量。

研究设计与样本

  • 开放标签随机对照试验,在英国17个中心纳入1100例接受侵入性冠状动脉造影的稳定型心绞痛或非ST段抬高型心肌梗死患者。

主要发现

  • 造影+FFR组中位检查血管数为4支(IQR 3-5)。
  • 中位医院费用:造影组£4136(IQR £2613-£7015),造影+FFR组£4510(IQR £2721-£7415),P=0.137。
  • EQ-5D-5L视觉模拟评分中位生活质量:两组均为75(造影组IQR 60-87,造影+FFR组IQR 60-90),P=0.88。
  • 临床事件:死亡5 vs 8,卒中3 vs 4,心肌梗死23 vs 22,非计划血运重建26 vs 33;复合分层事件率8.7%(48/552)vs 9.5%(52/548),P=0.64。

临床怎么用

  • 在稳定型心绞痛或非ST段抬高型心肌梗死患者接受侵入性造影时,常规系统FFR评估未显示费用或生活质量优势,临床决策需结合个体情况。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Measurement of fractional flow reserve (FFR) has an established role in guiding percutaneous coronary intervention. We tested the hypothesis that, at the stage of diagnostic invasive coronary angiography, systematic FFR-guided assessment of coronary artery disease would be superior, in terms of resource use and quality of life, to assessment by angiography alone. METHODS: We performed an open-label, randomized, controlled trial in 17 UK centers, recruiting 1100 patients undergoing invasive coronary angiography for the investigation of stable angina or non-ST-segment-elevation myocardial infarction. Patients were randomized to either angiography alone (angiography) or angiography with systematic pressure wire assessment of all epicardial vessels >2.25 mm in diameter (angiography+FFR). The coprimary outcomes assessed at 1 year were National Health Service hospital costs and quality of life. Prespecified secondary outcomes included clinical events. RESULTS: In the angiography+FFR arm, the median number of vessels examined was 4 (interquartile range, 3-5). The median hospital costs were similar: angiography, £4136 (interquartile range, £2613-£7015); and angiography+FFR, £4510 (£2721-£7415; P=0.137). There was no difference in median quality of life using the visual analog scale of the EuroQol EQ-5D-5L: angiography, 75 (interquartile range, 60-87); and angiography+FFR, 75 (interquartile range, 60-90; P=0.88). The number of clinical events was as follows: deaths, 5 versus 8; strokes, 3 versus 4; myocardial infarctions, 23 versus 22; and unplanned revascularizations, 26 versus 33, with a composite hierarchical event rate of 8.7% (48 of 552) for angiography versus 9.5% (52 of 548) for angiography+FFR (P=0.64). CONCLUSIONS: A strategy of systematic FFR assessment compared with angiography alone did not result in a significant reduction in cost or improvement in quality of life. REGISTRATION: URL: https://www. CLINICALTRIALS: gov; Unique identifier: NCT01070771.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Stables RH, Mullen LJ, Elguindy M, et al. Routine Pressure Wire Assessment Versus Conventional Angiography in the Management of Patients With Coronary Artery Disease: The RIPCORD 2 Trial. Circulation. 2022. PMID: 35946404. doi:10.1161/CIRCULATIONAHA.121.057793

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。